Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Latry

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|April 30, 2010
How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system databasePhilippe Latry, Mathieu Molimard, Bernard Bégaud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2012
Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement databasePhilippe Latry, Karin Martin-Latry, Marianne Lafitte, et al.
Fundamental & Clinical Pharmacology|July 7, 2011
Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health interventionPhilippe Latry, Karin Martin-Latry, Anne Labat, et al.
British Journal of Clinical Pharmacology|December 18, 2003
Differences between clinical trials and postmarketing useKarin Martin, Bernard Bégaud, Philippe Latry, et al.
BMC Cardiovascular Disorders|July 28, 2011
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort studyPhilippe Latry, Mathieu Molimard, Bernard Dedieu, et al.
Archives of Cardiovascular Diseases|February 4, 2022
One-year care pathway after acute myocardial infarction in 2018: Prescription, medical care and medication adherence, using a French health insurance reimbursement databaseKarin Martin-Latry, Philippe Latry, Camille Berges, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 22, 2007
Psychotropic drugs use and risk of heat-related hospitalisationKarin Martin-Latry, Marie-Pierre Goumy, Philippe Latry, et al.
Therapie|June 3, 2005
[Celecoxib prescription: data from the "Sécurité Sociale" database of the Aquitaine Region, South-Western, France]Annie Fourrier-Réglat, Ségolène de Bailliencourt, Mathieu Molimard, et al.
Pharmacoepidemiology and Drug Safety|February 24, 2006
Use of psychotropic drugs in 0 to 5 years old children in Aquitaine (France): prevalence and associated factorsLaurie Lévy, Corinne Martin-Guehl, Nathalie Lechevallier-Michel, et al.
Clinical Therapeutics|July 22, 2008
Adherence to anti-inflammatory treatment for asthma in clinical practice in FrancePhilippe Latry, Marion Pinet, Anne Labat, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|April 30, 2010
How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system databasePhilippe Latry, Mathieu Molimard, Bernard Bégaud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2012
Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement databasePhilippe Latry, Karin Martin-Latry, Marianne Lafitte, et al.
Fundamental & Clinical Pharmacology|July 7, 2011
Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health interventionPhilippe Latry, Karin Martin-Latry, Anne Labat, et al.
British Journal of Clinical Pharmacology|December 18, 2003
Differences between clinical trials and postmarketing useKarin Martin, Bernard Bégaud, Philippe Latry, et al.
BMC Cardiovascular Disorders|July 28, 2011
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort studyPhilippe Latry, Mathieu Molimard, Bernard Dedieu, et al.
Archives of Cardiovascular Diseases|February 4, 2022
One-year care pathway after acute myocardial infarction in 2018: Prescription, medical care and medication adherence, using a French health insurance reimbursement databaseKarin Martin-Latry, Philippe Latry, Camille Berges, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 22, 2007
Psychotropic drugs use and risk of heat-related hospitalisationKarin Martin-Latry, Marie-Pierre Goumy, Philippe Latry, et al.
Therapie|June 3, 2005
[Celecoxib prescription: data from the "Sécurité Sociale" database of the Aquitaine Region, South-Western, France]Annie Fourrier-Réglat, Ségolène de Bailliencourt, Mathieu Molimard, et al.
Pharmacoepidemiology and Drug Safety|February 24, 2006
Use of psychotropic drugs in 0 to 5 years old children in Aquitaine (France): prevalence and associated factorsLaurie Lévy, Corinne Martin-Guehl, Nathalie Lechevallier-Michel, et al.
Clinical Therapeutics|July 22, 2008
Adherence to anti-inflammatory treatment for asthma in clinical practice in FrancePhilippe Latry, Marion Pinet, Anne Labat, et al.
Pageof 2